Tirzepatide Weight Loss
in Torrance
Dual-action GIP and GLP-1 therapy with in-person medical evaluation, individualized dosing, and ongoing clinical supervision.
Important: Tirzepatide is a prescription medication. Treatment is provided only after an in-person medical evaluation by a licensed provider who confirms clinical appropriateness. Online purchases, if any, are prepaid credits for consultation and potential treatment. If you are not a candidate, you will receive a full refund or the same credit may be applied to another eligible service.
Tirzepatide at a Glance
Tirzepatide is a dual GIP and GLP-1 receptor agonist used in FDA-approved medicines for chronic weight management and type 2 diabetes. At Skin Works, the program begins with an in-person medical evaluation and continues with clinician-directed dosing, follow-up, and medication supplied through licensed pharmacy channels.
What Is Tirzepatide?
Tirzepatide is a prescription medication that activates both GIP and GLP-1 receptors, the two metabolic pathways involved in appetite regulation, insulin sensitivity, and energy balance. Targeting both at once is what distinguishes it from single-pathway GLP-1 medications.
Dual-Receptor Mechanism
Tirzepatide activates both GIP and GLP-1 receptors, which are involved in appetite regulation, glucose control, and energy balance.
Personalized Dosing
Dosing begins at a low level and is increased only when clinically appropriate. Your provider reviews tolerance, side effects, progress, and treatment goals before dose changes.
Medical Oversight and Licensed Pharmacy Supply
Treatment is prescribed and monitored by a licensed clinician, with medication sourced through licensed pharmacy channels according to the treatment plan.
A provider consultation reviews medical history, goals, dosing, and whether tirzepatide is clinically appropriate.
Who Tirzepatide Is Best For
This page is educational. An in-person medical evaluation is required to confirm candidacy and build a safe, appropriate plan.
- Adults seeking a medically supervised approach to weight loss
- Patients who have not reached their goals through diet and exercise alone
- Patients comfortable with weekly injections and ongoing provider check-ins
- No personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- Not pregnant, planning pregnancy, or breastfeeding
What We Evaluate Before Prescribing
Full medical history, current medications, and prior weight-loss attempts
Contraindications, including thyroid and pancreatic history
Prior experience with GLP-1 or GIP medications, if any
Realistic goals, timeline, and appropriate starting dose
Whether in-clinic dosing or an eventual take-home protocol fits your schedule
Whether a different medical weight-loss approach may be a better fit for you
Before You Book a Tirzepatide Consultation
Question 1 of 4What would you like to discuss with the provider?
Have you used a GLP-1 or GIP medication before?
Which follow-up format would be easiest for you?
How would you like to continue?
Thanks. Choose whichever way you’d like to continue:
How Tirzepatide Works
Dual Mechanism
Activates both GIP and GLP-1 receptors, distinguishing tirzepatide from medications that target GLP-1 alone.
Appetite Suppression
Can reduce appetite and food intake while slowing gastric emptying. Response and side effects vary by patient and dose.
Blood Sugar Support
Tirzepatide also affects glucose regulation and insulin response. Your medical history determines whether treatment is appropriate.
Weight Loss Over Time
In the pivotal SURMOUNT-1 obesity trial, average weight reduction at 72 weeks was about 15% to 21% depending on dose. Individual results vary.
Tirzepatide vs. Semaglutide
Both are effective GLP-1 medications. Your provider will recommend the right option after your evaluation.
Mechanism and Average Weight Reduction
Semaglutide targets GLP-1, while tirzepatide targets both GIP and GLP-1. In a 72-week head-to-head obesity trial, average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide. Individual results vary.
Blood Sugar Support and Take-Home Dosing
Both medications require medical screening, individualized dosing, and follow-up. If take-home dosing is appropriate, your provider will explain storage, injection technique, and follow-up requirements.
Pricing
Semaglutide starts at $370 per month and tirzepatide starts at $380 per month. The small difference in starting price reflects the dual-action formulation, not a difference in the level of provider care.
Typical Results Timeline
Starting Dose and Tolerance
Treatment begins at the provider-selected starting dose. Appetite changes and gastrointestinal side effects can occur early, so hydration, nutrition, and tolerance are reviewed.
Dose Review
Dose changes are based on tolerance, response, and clinical judgment rather than a fixed schedule for every patient.
Ongoing Weight-Loss Progress
Weight change usually accumulates over time. Short-term results vary widely, and the largest published obesity outcomes were measured over longer treatment periods rather than a few months.
Long-Term Follow-Up
Ongoing care focuses on response, side effects, nutrition, activity, dose appropriateness, and a sustainable plan. Continued treatment decisions are made with your clinician.
Medication preparation is handled with clinical oversight, clear dosing instructions, and provider review at each stage.
What Is Included in Your Program
Medical Evaluation and Eligibility Screening
In-clinic assessment by a licensed provider before any prescription is written.
Personalized Dose Titration
Your provider adjusts your dose based on how your body responds. Not a standard protocol.
In-Clinic Dosing or Take-Home Option
Start in clinic with full oversight. Once established, your provider may clear you to take syringes and supplies home. Same medication, same pharmacy, same price.
Medication From Licensed Pharmacy Sources
Medication is supplied through licensed pharmacy channels according to the prescription and treatment plan.
Side Effect Support
The clinical team reviews common side effects, hydration, nutrition, and when symptoms should be reported to the provider.
Nutrition and Habit Guidance
Practical nutrition and habit guidance is discussed alongside medication treatment and follow-up.
Progress Reviews
Photos, measurements, and plan adjustments so your program evolves as you do.
Not sure whether tirzepatide or semaglutide is the better fit? Text us a question and we’ll help you decide.
Text Us a QuestionWhat Happens After You Book
Consultation
Meet with a licensed provider in clinic to review your health history, current medications, prior weight-loss treatment, and goals.
Medical Evaluation
If tirzepatide is clinically appropriate, the provider reviews the prescription, starting dose, common side effects, precautions, and follow-up plan.
Weekly Dosing
Treatment is typically dosed weekly. Depending on the prescription and provider instructions, dosing may occur in clinic or through an approved take-home plan.
Follow-Up
Follow-up visits review weight change, tolerance, side effects, nutrition, and whether the dose or overall plan should change.
Want to ask about eligibility, prior GLP-1 use, dose levels, monthly pricing, or what happens at the first appointment?
Call (844) 759-6757Program Fees
All packages include doses based on your provider-approved protocol. First-time patients save $100 on any package. Actual dosing determined at consultation. Tap any treatment below to see full details and package pricing.
Frequently Asked Questions
How is tirzepatide different from semaglutide?
Tirzepatide targets two receptors, GLP-1 and GIP, while semaglutide targets only GLP-1. This dual mechanism may support stronger appetite regulation and greater weight reduction for some patients. Your provider will recommend the right option based on your health profile. See our full comparison guide for more detail.
Is tirzepatide FDA approved for weight loss?
Tirzepatide is the active ingredient in Zepbound, which is FDA approved for chronic weight management in eligible adults, and in Mounjaro, which is FDA approved for type 2 diabetes. The specific medication and formulation prescribed for you must be determined by your clinician.
What results can I expect?
Results vary based on medical history, dose, consistency, nutrition, activity, and follow-up. Your provider will help set realistic expectations and adjust your plan as your body responds.
How often do I need to come in?
Most patients begin with regular in-clinic visits for dose administration and monitoring. Once established on your protocol, your provider may clear you to administer doses at home with supplied syringes and instructions at no additional cost.
Is tirzepatide safe?
Side effects are typically gastrointestinal and may be more noticeable during dose changes. Your provider reviews your full medical history before prescribing. All treatment decisions are made by a licensed clinician after an in-person evaluation.
Can I switch from semaglutide to tirzepatide?
Some patients may be candidates to transition. Your provider will evaluate your history, current dose, tolerance, goals, and contraindications before recommending a safe starting point.
Does the New Patient Rate apply to every visit?
No, the New Patient Rate is calculated independently from the standard rate and applies to your first visit only. Ongoing months are billed at the standard package rate shown above.
Tirzepatide Weight Loss in Torrance and the South Bay
Visit us at 2573 Pacific Coast Highway, Suite B in Rolling Hills Plaza, Torrance, with free parking on site. Hours: Monday to Saturday 9:00 AM to 7:00 PM and Sunday 10:00 AM to 5:00 PM. We regularly see patients from Redondo Beach, Manhattan Beach, Hermosa Beach, Palos Verdes, Gardena, Carson, Lomita, and San Pedro.
Complimentary Consultations Available Talk With a Provider About Tirzepatide Your first visit is an in-person medical evaluation to review eligibility, prior treatment, dosing, precautions, and program pricing before any prescription is made. |
Medical Disclaimer: Tirzepatide is a prescription medication. Treatment is provided only after an in-person medical evaluation confirming clinical appropriateness. This page is for informational purposes only and does not constitute medical advice. Individual results vary.
Medication: Tirzepatide is the active ingredient in FDA-approved Zepbound for chronic weight management in eligible patients and Mounjaro for type 2 diabetes. The specific product, formulation, dose, and dispensing pharmacy are determined through the prescription and clinical treatment process.
Pricing: The New Patient Rate applies to the first eligible visit only and is calculated separately from the standard monthly package rate. It cannot be combined with another offer.
Financing: Payment plans are provided by third-party lenders and are subject to approval and lender terms. Skin Works Medical Spa, 2573 Pacific Coast Highway, Suite B, Torrance, CA 90505, (844) 759-6757.